Fidelity International’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,187,271
Closed -$89.3M 973
2024
Q1
$89.3M Buy
+4,187,271
New +$50.1M 0.09% 239

Fidelity International's FUSN Position: Q2 2024 in Review

Fidelity International sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 4,187,271 shares — an estimated $89.3M sold.

Fidelity International first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $89.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Fidelity International reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Fidelity International sold 4,187,271 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $89.3M.
  • Fidelity International first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
  • Fidelity International's Fusion Pharmaceuticals Inc. Common Shares position peaked at $89.3M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Fidelity International's 13F filing for Q2 2024, filed 13 Aug 2024.